Singh Prabhsimran, Millson Charles, Huang Chao, Driver Robert J
University of York, York, UK
Department of Hepatology, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK.
BMJ Open. 2025 Feb 18;15(2):e089369. doi: 10.1136/bmjopen-2024-089369.
Hereditary haemochromatosis (HH) is the most common genetic condition among populations of northern European ancestry, but it does not have a specific International Classification of Diseases 10th revision (ICD-10) diagnosis code. HH is commonly assigned the ICD-10 code E83.1 defined as 'disorders of iron metabolism'. However, the E83.1 diagnosis code is also applied to patients with transfusion-related iron overload and hyperferritinaemia from non-iron loading conditions. Venesection is the main treatment option for patients with HH and is assigned the Office of Population, Census and Surveys Classification of Interventions and Procedures, 4th revision (OPCS-4) code X36.2. We aimed to develop a novel algorithm to identify haemochromatosis patients with C282Y homozygosity from electronic patient records (EPR) using ICD-10 and OPCS-4 codes.
The Hospital Episode Statistics Admitted Patient Care (APC) database was used to identify all patients with the ICD-10 code E83.1 from 1 April 2018 to 31 March 2023 in our NHS Trust. Case notes were reviewed to evaluate the presence of HH, genotype, medical history and associated procedures. Algorithms were generated using Stata MP V.18 by applying a combination of ICD-10 and OPCS-4 codes to all patients with the diagnosis code E83.1 including those without HH gene mutations.
A total of 9264 patient episodes were identified from the HES APC database corresponding to 787 unique patients: 479 (60.9%) C282Y homozygous, 107 (13.6%) C282Y/H63D compound heterozygotes, 42 (5.3%) other HH genetic mutations and 159 (20.2%) without any HH gene mutations. Six algorithms were developed to identify patients with HH within inpatient EPR, all of which showed improved positive predictive value (PPV) compared with the baseline cohort. The application of the OPCS-4 code for venesection (X36.2) in five of the algorithms resulted in large improvements in specificity and increased all their PPVs to >70%. Algorithms 4 and 6 had the best PPV at 74.3% and 74.4%, respectively, and included the removal of patients with ICD-10 codes associated with transfusion-related iron overload and other conditions treated with venesection.
These novel algorithms represent a more reliable method to detect haemochromatosis patients with C282Y homozygosity from EPR than the single ICD-10 code E83.1. It may be applied to large administrative datasets for investigation of HH in population studies.
遗传性血色素沉着症(HH)是北欧血统人群中最常见的遗传疾病,但它没有特定的国际疾病分类第十版(ICD - 10)诊断代码。HH通常被分配ICD - 10代码E83.1,定义为“铁代谢紊乱”。然而,E83.1诊断代码也适用于输血相关铁过载和非铁负荷条件下高铁蛋白血症的患者。静脉放血是HH患者的主要治疗选择,被分配人口普查与调查干预和程序分类第四版(OPCS - 4)代码X36.2。我们旨在开发一种新算法,使用ICD - 10和OPCS - 4代码从电子病历(EPR)中识别C282Y纯合子的血色素沉着症患者。
使用医院事件统计住院患者护理(APC)数据库,识别我们国民健康服务信托基金中2018年4月1日至2023年3月31日期间所有具有ICD - 10代码E83.1的患者。审查病例记录以评估HH的存在、基因型、病史和相关程序。通过将ICD - 所有诊断代码为E83.1的患者,包括那些没有HH基因突变的患者,应用ICD - 10和OPCS - 4代码的组合,使用Stata MP V.18生成算法。
从HES APC数据库中总共识别出9264例患者事件,对应787名独特患者:479例(60.9%)为C282Y纯合子,107例(13.6%)为C282Y/H63D复合杂合子,42例(5.3%)为其他HH基因突变,159例(20.2%)没有任何HH基因突变。开发了六种算法来识别住院EPR中的HH患者,与基线队列相比,所有算法的阳性预测值(PPV)均有所提高。在五种算法中应用静脉放血的OPCS - 4代码(X36.2)导致特异性大幅提高,并将所有算法的PPV提高到>70%。算法4和算法6的PPV最佳,分别为74.3%和分别为74.4%,并包括排除具有与输血相关铁过载和其他接受静脉放血治疗的疾病相关的ICD - 10代码的患者。
这些新算法代表了一种比单一ICD - 10代码E83.1更可靠的方法,可从EPR中检测C282Y纯合子的血色素沉着症患者。它可应用于大型行政数据集,用于人群研究中HH的调查。